ARCHIVES

Brigham & Women’s Suspends Controversial Morcellation Study As Apparent “Difference of Opinion” with FDA Comes to Light

This article is from The Cancer Letter archive.

Vol. 40 No. 45 | December 5, 2014

Download PDF Visit The Full Archive

Related Articles

CDC Offers Funds For 5-A-Day Program; CDC PA Available

May 14, 1999

ICCCR Loses Support Of French, DeVita Resigns As President, Fischinger To Take Over

July 17, 1992

ACS President & COO Resigns Unexpectedly; Was Seen as Contender for CEO Position

December 19, 2014

Evidence Links Anemia Drugs With Leukemic Transformation

December 28, 2007

Arbuck Leaves NCI to Guide BMS Oncology Pipeline.

September 7, 2001

Too Few Minority Scientists Enter Careers In Public Health, Oncology, Bynum Reports

March 24, 1989